BioMarin Pharmaceutical
BMRN
#844
Rank
$20.84 B
Marketcap
$112.18
Share price
-0.02%
Change (1 day)
25.52%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: $20.84 Billion

As of February 2023 BioMarin Pharmaceutical has a market cap of $20.84 Billion. This makes BioMarin Pharmaceutical the world's 844th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 2001 to 2023

End of year Market Cap

Year Market cap Change
2023$20.84 B8.4%
2022$19.23 B18.58%
2021$16.22 B1.9%
2020$15.91 B4.69%
2019$15.20 B0.18%
2018$15.17 B-3.08%
2017$15.66 B9.92%
2016$14.24 B-15.8%
2015$16.92 B25.55%
2014$13.47 B33.54%
2013$10.09 B63.05%
2012$6.18 B57.63%
2011$3.92 B31.8%
2010$2.97 B56.88%
2009$1.89 B6.88%
2008$1.77 B-48.31%
2007$3.43 B128.67%
2006$1.50 B87.69%
2005$0.80 B94.33%
2004$0.41 B-17.21%
2003$0.49 B31.3%
2002$0.37 B-46.16%
2001$0.70 B

End of Day market cap according to different sources

On Feb 6th, 2023 the market cap of BioMarin Pharmaceutical was reported to be:

$20.84 Billion
by Yahoo Finance
$20.84 Billion
by CompaniesMarketCap
$20.84 Billion
by Nasdaq
$20.80 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$119.42 B 472.80%๐Ÿ‡ซ๐Ÿ‡ท France
$3.22 B-84.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.56 B-97.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.43 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.66 B-82.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.65 B-92.08%๐Ÿ‡บ๐Ÿ‡ธ USA